Study details
Enrolling now
Stimulant Effects on Disruptive Behavior
Matthew J O'Brien, PhD, BCBA-D
NCT IDNCT03420339ClinicalTrials.gov data as of Apr 2026
Phase
Phase 4
Target enrollment
10
Study length
about 8.8 years
Ages
4–12
Locations
1 site in IA
About this study
Researchers are testing whether stimulant medication affects disruptive behavior, function, preference and choice in children with Attention Deficit Hyperactivity Disorder (ADHD). The trial will assess how stimulants impact a child's preferences for social and nonsocial items, their disruptive behaviors, and their ability to make choices. Participants will take the medication or not take it during certain visits.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Stimulant
PhasePhase 4
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low4%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Secondary: Compliance
Body systems
Psychiatry / Mental Health